With a PhD in Pharmacology and Toxicology from Imperial College London Mukesh Summan is a board-certified toxicologist with more than 15 years of experience in safety assessment and regulatory toxicology.
Prior to joining Kerry, Mukesh provided regulatory and toxicology guidance to support the development of new medicines as a Division Director in the US Food and Drug Administration, Centre for Drug Evaluation and Research.
At Kerry, Mukesh supports the safety assessment of Kerry’s food, beverage and supplement ingredients ensuring the highest safety standards.
Ashwagandha continues to face regulatory scrutiny in Europe, highlighting the need for high-quality safety data generated using internationally recognised standards. A recent OECD- and GLP-compliant safety assessment of a fully characterised root-and-leaf ashwagandha extract demonstrated no genotoxicity, no treatment-related adverse effects in a 90-day study, normal liver findings and no adverse endocrine effects, even at…
Botanical ingredients like ashwagandha are facing growing scrutiny across Europe, often fuelled by misinformation and outdated myths. Despite centuries of safe use, these ancient botanicals are now subject to misplaced concerns. To bring clarity to the conversation, the first episode of KHNI Talks podcasts features scientific experts who take a deep dive into the evidence surrounding…
